IP Library Granted Patent US 9,664,677
Granted Patent B2
US 9,664,677 · App. 13/090,199 · Granted May 30, 2017

Polymer-nanostructure composition for selective molecular recognition

Inventors: Michael S. Strano (Lexington, MA); Jingqing Zhang (Cambridge, MA); Paul Walter Barone (Allston, MA); Daniel A. Heller (Rye Brook, NY); Jong-Ho Kim (Ansan, KR)
Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
G01N33/542B82Y30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,664,677
App. No.
13/090,199
Granted
May 30, 2017
Kind
B2
Abstract

A composition can include a complex, where the complex includes a photoluminescent nanostructure and a polymer free from selective binding to an analyte, the polymer adsorbed on the photoluminescent nanostructure, and a selective binding site associated with the complex.

Claims (15)

1. A composition, comprising:

a complex, wherein the complex includes:

a nanostructure, wherein the nanostructure is a photoluminescent nanostructure,

wherein the photoluminescent nanostructure is a single-walled carbon nanotube; and

a polymer, the polymer adsorbed on the nanostructure and the polymer being free from selective binding to an analyte in the absence of being adsorbed on the nanostructure,

wherein the polymer is a boronic acid functionalized phenoxy dextran; and

a selective binding site for the analyte on the complex.

2. The composition of claim 1 , wherein the analyte is a monosaccharide, a polysaccharide, an amino acid, a nucleotide, an oligonucleotide, a lipid, a polylipid, a steroid, a peptide, a protein, riboflavin, or nitric oxide.

3. The composition of claim 1 , wherein the analyte is 17-α-estradiol, 2,4-dinitrophenol, acetylcholine chloride, α-tocopherol, adenosine, adenosine-5′-triphosphate, cyclic adenosine monophosphate, creatinine, cytidine, D-aspartic acid, D-fructose, D-galactose, D-glucose, D-mannose, dopamine, glycine, guanosine, histamine, L-ascorbic acid, L-citrulline, L-histidine, L-thyroxine, melatonin, NADH, quinine, salicylic acid, serotonin, sodium azide, sodium pyruvate, sucrose, thymidine, tryptophan, tyramin or urea.

4. The composition of claim 1 , further comprising an amount of the analyte.

5. The composition of claim 4 , wherein the analyte is a therapeutic.

6. A system comprising:

the composition of claim 1 ;

an electromagnetic radiation source having an excitation wavelength directed at the composition; and

a detector configured to receive an emission wavelength from the composition.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 6, 2012
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028726/0990 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2011
From: STRANO, MICHAEL S.; ZHANG, JINGQING; BARONE, PAUL WALTER; HELLER, DANIEL ALAN; KIM, JONG-HO
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 027193/0294 →
Continuity (2)
Provisional Application 61325599 · Apr 19, 2010
Related Publication 20110257033A1 · Oct 20, 2011